Industry Segment

Diagnostics

Browse market forecasts, competitive intelligence, demand signals and strategic research across Diagnostics.

Research Coverage

Explore the focus areas

Biotechnology→Clinical Trials→Diagnostics→Drug Pipeline→Healthcare IT→

Testing demand is becoming more selective as reimbursement models increasingly link diagnostic use to measurable clinical impact rather than volume. Providers are reducing reliance on routine, repeat testing where outcomes remain unchanged, which is shifting demand toward diagnostics that directly influence treatment decisions. This change is elevating the importance of accuracy and clinical validation, as even small improvements in diagnostic confidence can reduce downstream interventions. At the same time, high-complexity testing continues expanding in areas such as oncology and genetic profiling, where diagnostics play a central role in guiding therapy rather than confirming conditions.

Adoption patterns are diverging across care settings as the value of rapid diagnostics depends heavily on where they are used. Emergency and urgent care environments are increasing use of point-of-care testing because faster results enable immediate decisions that reduce admissions and treatment delays. In contrast, primary care settings are adopting more gradually due to budget limitations, regulatory requirements, and less immediate economic benefit from rapid testing. Diagnostics are also becoming more integrated into chronic disease management, where frequent monitoring supports adherence and early intervention, creating steady demand beyond episodic care.

Patient access is playing a larger role in shaping diagnostic demand as testing expands beyond traditional clinical environments. Retail clinics and pharmacy-based providers are incorporating diagnostics into routine services, making testing more accessible and convenient. This is encouraging earlier and more frequent testing, particularly for preventive and wellness-related use cases. However, adoption depends on the ability to integrate results into clinical workflows, as disconnected systems can limit the practical value of increased access.

Operational factors are continuing to influence how diagnostic services scale, particularly in regions where sample collection and transport infrastructure is limited. Laboratories are focusing on improving turnaround times and expanding collection networks to maintain service reliability. At the same time, advances in testing technology are enabling more flexible deployment models, including decentralized and near-patient testing. These shifts are supporting gradual expansion of diagnostic services into new settings, while maintaining the need for accuracy, compliance, and efficiency.

Latest Reports

449 reports
Russia Flu Diagnostic and Treatment Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type Of Flu (Type A, Type B), By Offering (Diagnostics (Rapid Influenza Diagnostic Test, Rapid Molecular Assay, Others), Therapeutics), By Age Group (0-14 Years, 15-64 Years, >=65 Years), And By End-User (Hospital Laboratory, Outpatient Clinic, Reference Laboratory) - Forecasts From 2022 To 2027
Healthcare/August 2022

Russia Flu Diagnostic and Treatment Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type Of Flu (Type A, Type B), By Offering (Diagnostics (Rapid Influenza Diagnostic Test, Rapid Molecular Assay, Others), Therapeutics), By Age Group (0-14 Years, 15-64 Years, >=65 Years), And By End-User (Hospital Laboratory, Outpatient Clinic, Reference Laboratory) - Forecasts From 2022 To 2027

The Russian flu diagnostic and treatment market is projected to grow at a CAGR of 6.38% throughout the forecast period and reach a market value of US$846.381 million by 2027. The market was valued at US$548.825 million in 2020. The flu ...

South Korea Flu Diagnostic and Treatment Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type Of Flu (Type A, Type B), By Offering (Diagnostics (Rapid Influenza Diagnostic Test, Rapid Molecular Assay, Others), Therapeutics), By Age Group (0-14 Years, 15-64 Years, >=65 Years), And By End-User (Hospital Laboratory, Outpatient Clinic, Reference Laboratory) - Forecasts From 2022 To 2027
Healthcare/August 2022

South Korea Flu Diagnostic and Treatment Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type Of Flu (Type A, Type B), By Offering (Diagnostics (Rapid Influenza Diagnostic Test, Rapid Molecular Assay, Others), Therapeutics), By Age Group (0-14 Years, 15-64 Years, >=65 Years), And By End-User (Hospital Laboratory, Outpatient Clinic, Reference Laboratory) - Forecasts From 2022 To 2027

The South Korean flu diagnostic and treatment market is projected to grow at a CAGR of 10.53% throughout the forecast period. The market was valued at US$642.107 million in 2020 and is expected to reach a market size of US$1,294.081 million...

Thailand Flu Diagnostic and Treatment Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type Of Flu (Type A, Type B), By Offering (Diagnostics (Rapid Influenza Diagnostic Test, Rapid Molecular Assay, Others), Therapeutics), By Age Group (0-14 Years, 15-64 Years, >=65 Years), And By End-User (Hospital Laboratory, Outpatient Clinic, Reference Laboratory) - Forecasts From 2022 To 2027
Healthcare/August 2022

Thailand Flu Diagnostic and Treatment Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type Of Flu (Type A, Type B), By Offering (Diagnostics (Rapid Influenza Diagnostic Test, Rapid Molecular Assay, Others), Therapeutics), By Age Group (0-14 Years, 15-64 Years, >=65 Years), And By End-User (Hospital Laboratory, Outpatient Clinic, Reference Laboratory) - Forecasts From 2022 To 2027

The Thailand flu diagnostic and treatment market is projected to grow at a CAGR of 7.03% throughout the forecast period. The market was valued at US$97.639 million in 2020 and is anticipated to reach a value of US$157.109 million by 2027. T...

North America Flu Diagnostic and Treatment Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type Of Flu (Type A, Type B), By Offering (Diagnostics (Rapid Influenza Diagnostic Test, Rapid Molecular Assay, Others), Therapeutics), By Age Group (0-14 Years, 15-64 Years, >=65 Years), By End-User (Hospital Laboratory, Outpatient Clinic, Reference Laboratory), And By Country - Forecasts From 2022 To 2027
Healthcare/August 2022

North America Flu Diagnostic and Treatment Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type Of Flu (Type A, Type B), By Offering (Diagnostics (Rapid Influenza Diagnostic Test, Rapid Molecular Assay, Others), Therapeutics), By Age Group (0-14 Years, 15-64 Years, >=65 Years), By End-User (Hospital Laboratory, Outpatient Clinic, Reference Laboratory), And By Country - Forecasts From 2022 To 2027

The North American flu diagnostic and treatment market is projected to grow at a CAGR of 13.66% throughout the forecast. The market was valued at US$13,844.604 million in 2020 and is expected to reach value of US$33,930.568 million by 2027....

Wearable Injectors Market Size, Share, Opportunities And Trends By Type (On-Body Wearable Injector, Off-Body Wearable Injector), By Application (Diabetes, Oncology, Cardiovascular diseases, Others) And By Geography - Forecasts From 2019 To 2024
Healthcare/March 2020

Wearable Injectors Market Size, Share, Opportunities And Trends By Type (On-Body Wearable Injector, Off-Body Wearable Injector), By Application (Diabetes, Oncology, Cardiovascular diseases, Others) And By Geography - Forecasts From 2019 To 2024

The wearable injectors market is projected to grow at a CAGR of XX.XX% to reach US$XX.XXX billion by 2023, from US$XX.XXX billion in 2017. The demand for wearable injectors is increasing due to the technological advancements coupled with a ...

Related Intelligence Hubs

Explore interconnected markets and cross-industry research.

ICT →Semiconductor →Chemicals and Materials →Consumer Goods →Business Opportunities →Aerospace and Defense →